Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/3544
Full metadata record
DC FieldValueLanguage
dc.contributor.authorErica Alves-
dc.date.accessioned2026-05-01T08:38:44Z-
dc.date.available2026-05-01T08:38:44Z-
dc.date.issued2026-05-01-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/3544-
dc.descriptionVol. 62, No. 7, p47en_US
dc.language.isoenen_US
dc.subjectLC-MS/MSen_US
dc.subjectpyarzinamide D3en_US
dc.subjectSPEen_US
dc.subjectSolid Phase Extractionen_US
dc.subjectElectrospray ionizationen_US
dc.subjectEuropean Medicine Agencyen_US
dc.subjectEMAen_US
dc.titleQuanitification of pyrazinamide in human plasma : development and validation of a liquid chromatography tandem mass spectrometry methoden_US
dc.typeOtheren_US
Appears in Collections:Vol62, No. 7, 2025

Files in This Item:
File Description SizeFormat 
1.pdfVol. 62, No. 7, p4779.85 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.